Publication | Closed Access

Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study

Severe Renal ImpairmentHepatitis CViral HepatitisPhase 2BAntiviral TherapyHepatitisVirologyAntiviral DrugMedicineGenotype 1